April 24-25, 2024

Pronovea Pharma Summit: Drug Safety & Risk Management

Vienna

Join UBC in Vienna

UBC is honored to be invited to speak at this event focused on patient safety. Our pharmacovigilance experts will be presenting on the use of AI in the preparation of periodic safety reports and safety signal management activities.

UBC provides integrated, comprehensive solutions to demonstrate safety across the product lifecycle. From managing clinical trial safety activities, to portfolio pharmacovigilance and RMPs, we provide expertise across all aspects of patient safety.
UBC Pinwheel logo

Meet With Us On-Site

Presentation

The Use of AI/ChatGPT in the Preparation of Safety Aggregate Reports and Safety Signal Management Activities

Wednesday, April 24, 1:50 PM

Laurent Vidal, Associate Director, Global Safety Writing & Christopher Henry, Safety Scientist

This presentation will cover:

Expectations towards:

– Regulatory compliance

– Safety data management and analyses

– Benefit risk evaluations

And concerns regarding:

– Management of confidentiality

– Consistency in the methods of analysis

– Human accountability in safety recommendations

Learn More About UBC

We are dedicated to uniting evidence and access for biopharma. Fill out the form to get in touch with our team and learn more.

Other Events

Scenic view of San Diego with palm trees and boats
Trade show
RSVP

Outsourcing in Clinical Trials Southern California 2026

Meet UBC at OCT SoCal to discuss evidence development solutions that generate meaningful real‑world insights for clinical and post‑market programs.
Aerial view of the downtown San Diego, California with the famed convention center as the focal point.
Trade show
RSVP

HUB and Specialty Pharmacy West Conference 2026

UBC is looking forward to engaging with industry partners at HUB and Specialty Pharmacy West 2026 to discuss patient access strategies that improve affordability, verification, and adherence support.
View of the Boston Seaport District near the Boston Convention Center
Trade show
RSVP

World Orphan Drug Congress 2026

Meet UBC at the World Orphan Drug Congress USA, the leading event for rare disease therapies and orphan drug development. Explore solutions for evidence generation, safety, and patient access.

Meet With Us On-Site

UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.